69 For approval: Final Draft Sefton Pharmaceutical Needs Assessment 2022-25 PDF 397 KB
Report of the Director of Public Health
Additional documents:
Minutes:
The Board considered the report of the Director of Public Health which outlined the process and key findings of the 2022-25 Sefton Pharmaceutical Needs Assessment and sought approval for publication before 1 October 2022. The Board also received a presentation accompanying the report.
RESOLVED: That
(1) |
the Sefton Pharmaceutical Needs Assessment (PNA) 2022-25 be approved and publication by 1 October 2022 be authorised, in accordance with its duties under the Health and Social Care Act 2012 and the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 as amended (the 2013 regulations);
|
(2) |
the content of the PNA, and the summary of methodology and key findings in this report, including the feedback received during the 60-day consultation period be noted; and
|
(3) |
the role of the updated Pharmaceutical Needs Assessment Information Pack for Local Authority Health and Wellbeing Boards (DHSC, October 2021) in guiding decisions about production of subsequent PNAs and supplementary statements; and the discharge of the Board’s responsibilities in relation to the PNA be noted. |
12. For approval: Final Draft Sefton Pharmaceutical Needs Assessment 2022-25
Additional documents: